01 / PURITY
HPLC Purity
Reverse-phase high-performance liquid chromatography separates the active peptide from related impurities and degradation products. Release criterion is a minimum of 99.0% purity by peak area.
≥ 99.0%
Independent Quality Verification
Batch-tested. Lab-verified. Fully documented.
Every product lot is analyzed by accredited third-party laboratories before it ships. Search the batch ledger by lot ID, review purity values, and download the matching Certificate of Analysis.
Transparency built into every release.
We separate manufacturing from verification so the data you see comes from an independent lab, not our own bench.
Triumphant Labs sends sealed samples to accredited partner laboratories for blind testing. Results are reviewed against release thresholds before any lot is approved for inventory.
The batch ledger below lets you inspect recent purity values, assay scope, and lab partner for each certificate — all tied to the exact lot printed on your vial.
What the release panel covers
Independent lab testing
Our quality program focuses on the assays researchers ask for most: identity confirmation, purity quantification, endotoxin screening, sterility assurance, and residual solvent limits.
Identity confirmed by mass spectrometry
Purity quantified by HPLC
Endotoxin, sterility, and solvent screening
Batch-locked COA with every order
Latest COA · TL-26-0512
HPLC 99.72% — Passed
What we test
Five-panel release review
Each lot is held until identity, purity, endotoxin, sterility, and solvent results all clear their release thresholds.
02 / IDENTITY
Mass Spectrometry
Electrospray ionization mass spectrometry confirms the expected molecular weight within ±1 Da, establishing identity for the sequence in every vial we release.
MW verified
03 / ENDOTOXIN
Endotoxin Screening
Kinetic chromogenic Limulus Amebocyte Lysate assay detects gram-negative bacterial endotoxins. Every batch must fall below the 0.5 EU/mg release threshold.
< 0.5 EU/mg
04 / STERILITY
Sterility & Bioburden
USP <71> direct inoculation sterility and USP <61> microbial enumeration are performed under aseptic conditions to confirm absence of viable microorganisms.
USP <71>
05 / SOLVENTS
Residual Solvents
Gas chromatography headspace analysis screens for trifluoroacetic acid and organic process solvents against ICH Q3C Class 2 and Class 3 safety thresholds.
ICH Q3C
Where we test
Independent lab partners
Release data is generated outside our facility by accredited laboratories with no stake in the outcome.
Accumark Labs
Anaheim, CAAccumark is a US-based (Anaheim, CA) lab that runs the biosafety assays HPLC-only testing skips—endotoxin and heavy metals—with a 48–72 hour turnaround. Every report lives at a unique, cryptographically signed URL rendered live from their lab system, so each COA can be scanned and verified rather than just trusted.
Chromate
United StatesChromate is a US-based independent lab for supplement and compound analysis, staffed by chemists trained across the US, Canada, Germany, and Singapore using literature-based methods and professional-grade instrumentation. Results are published through a dedicated Verify portal, and their unannounced testing program keeps results objective and free of vendor influence.
Bioviridian Inc
College Station, TXBioviridian is an independent US-based (College Station, TX) lab specializing in third-party peptide characterization—purity, identity, and net peptide content—via Agilent LC-MS with diode array detection, MALDI-MS, and HPLC. Every COA is searchable in their public database and backed by detailed impurity profiling, giving a transparent, verifiable record of each batch.
Batch ledger
Recent Certificates of Analysis
| Batch ID | Compound | Released | Lab | HPLC | Certificate |
|---|---|---|---|---|---|
| TL-26-0512 | BPC-157 · 10mg | JUL 08 2026 | Accumark & Chromate | 99.72% | |
| TL-26-0508 | TB-500 · 5mg | JUL 03 2026 | Accumark & Chromate | 99.41% | |
| TL-26-0501 | Semax · 30mg | JUN 28 2026 | Meridian BioLabs | 99.63% | |
| TL-26-0427 | Selank · 30mg | JUN 22 2026 | Northline Bioassay | 99.55% | |
| TL-26-0418 | GHK-Cu · 50mg | JUN 15 2026 | Accumark & Chromate | 99.71% | |
| TL-26-0409 | PT-141 · 10mg | JUN 09 2026 | Meridian BioLabs | 99.38% |
Synthesis & In-Process Control
Solid-phase peptide synthesis proceeds under controlled conditions with in-process yield, coupling efficiency, and appearance checks.
Internal QC Review
Our analytical team performs preliminary identity, purity, and appearance checks to confirm the batch is ready for independent verification.
Independent Testing
Sealed samples are sent blind to accredited partner laboratories so the final release data is generated outside our own facility.
COA Publication
Countersigned results are archived by batch ID, linked to the product page, and made available for download before the lot ships.
What does the release panel include?
Every production lot is reviewed through a five-panel program: HPLC purity, mass spectrometry identity, endotoxin screening, sterility and bioburden testing, and residual solvent analysis. A batch only releases once every panel meets its threshold.
How do I find the COA for my order?
Each vial and packing slip includes a batch ID. Enter that ID in the batch ledger above, or download the matching Certificate of Analysis directly from the product or order page.
Are the tests performed in-house?
No. Final release testing is performed by independent, accredited partner laboratories. Samples are submitted blind so the analytical data remains fully separate from our manufacturing operations.